Updates to the European Union Cosmetics Regulation (EC No 1223/2009) for 2025–2026

The European Union cosmetics market operates under one of the most stringent regulatory frameworks globally, ensuring a high level of consumer safety. The years 2025 and 2026 mark a significant phase of updates to the legal basis (Regulation EC No 1223/2009). These changes directly impact cosmetic manufacturers and brand owners, necessitating prompt formulation revisions and documentation updates.

Key Regulatory Changes

Based on the opinions of the Scientific Committee on Consumer Safety (SCCS), the European Commission has adopted several "Omnibus" regulations that update the lists of prohibited and restricted substances (Annexes II and III).

1. Bans on CMR Substances: Following the latest amendments to the CLP (Classification, Labelling and Packaging) Regulation, new Carcinogenic, Mutagenic, and Reprotoxic (CMR) substances have been added to the list of prohibited substances in cosmetic products. For instance, a complete ban on the use of TPO (Trimethylbenzoyl Diphenylphosphine Oxide) comes into effect on September 1, 2025.
2. Restrictions on Active Ingredients: Permissible concentration limits are being tightened for widely used ingredients, such as Vitamin A derivatives (Retinol, Retinyl Acetate), Alpha-Arbutin, Kojic Acid, and certain UV filters.
3. Regulation of Nanomaterials: In 2025, a ban on 12 specific nanomaterials was implemented, and the use of others (e.g., Hydroxyapatite nano) was strictly regulated based on the latest toxicological assessments.

Ensuring Compliance and Risk Management

Non-compliance with updated EU regulations poses severe legal and financial risks, including product recalls. Every cosmetic product must possess an updated Cosmetic Product Safety Report (CPSR) reflecting the latest toxicological data and must be properly notified on the CPNP (Cosmetic Products Notification Portal).

Versus Labs Regulatory Expertise

As a certified Private Label manufacturer, Versus Labs integrates legal compliance assessment into every stage of product development. Our Regulatory Affairs department continuously monitors publications from the European Commission and the SCCS.

We ensure that all formulations we develop and manufacture fully comply with current and upcoming EU requirements. We provide our B2B partners with the complete documentation package necessary for the smooth and lawful placement of products on the European Union market, thereby minimizing regulatory risks and ensuring business continuity.